Advanced liver organoids were able to secrete functional FVIII that could be used to stop bleeding in mice with hemophilia A, ...

Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...

Pfizer Inc. (PFE) on Thursday said that its therapy Hympavzi demonstrated improvement in bleeding outcomes for adults and adolescents living with hemophilia A or B with inhibitors in a late-stage ...

A genetic bleeding disorder, haemophilia worsens quality of life, can cause deformities and disabilities and in the worst of ...

Pfizer Inc. (NYSE:PFE) ranks among the best set-it-and-forget-it stocks to buy. On June 26, Pfizer Inc. (NYSE:PFE) declared ...

Hemlibra (emicizumab-KXWH) safely reduces bleeding episodes in people with hemophilia A without inhibitors, resulting in a ...

Researchers have created liver tissue that grows its own blood vessels, improving research into hemophilia and liver damage.

The petition was filed by Prema Ram who appeared in the Civil Services Examination conducted by the Union Public Service Commission (UPSC) in May this year ...